Reach your audience. Get results.
Rely on the experience, guidance, and superior media targeting of Business Wire for your global press release distribution.
Public RelationsMaximize the reach of your news with our press release distribution services and partnerships. Investor RelationsReach and engage investors, shareholders, analysts, and media with our complete suite of IR services and tools. Distribution & AnalyticsTarget your news, reach your audiences, and understand the impact of your press releases with our analytics reports. |
Latest News
Today is June 01, 2024.
All times in Eastern Daylight Time.
-
CAMAS, Wash.--(BUSINESS WIRE)--nLIGHT, Inc. (Nasdaq: LASR), a leading provider of high-power semiconductor and fiber lasers used in the industrial, microfabrication, and aerospace and defense marke... more »
-
NASHVILLE, Tenn.--(BUSINESS WIRE)--Revance to Release First Quarter 2024 Financial Results on Thursday, May 9, 2024 more »
-
ImmunityBio, Serum Institute of India Agree on an Exclusive Arrangement for Global Supply of Bacillus Calmette-Guerin (BCG) Across All Cancer TypesCULVER CITY, Calif.--(BUSINESS WIRE)--ImmunityBio, Inc. (NASDAQ: IBRX), has signed an exclusive global arrangement with the Serum Institute of India, the world’s largest manufacturer of vaccines by... more »
-
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith reminds investors of the upcoming June 28, 2024 deadline to file a lead plaintiff motion in the case filed on behalf of investors who ... more »
-
Expedia Group Reports First Quarter 2024 ResultsSEATTLE--(BUSINESS WIRE)--Expedia Group, Inc. (NASDAQ: EXPE) announced financial results today for the first quarter ended March 31, 2024. “Our first quarter results met our guidance with a revenue... more »
-
Arrowhead Pharmaceuticals Earns $50 Million Milestone from Royalty PharmaPASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced a $50 million milestone payment was received from Royalty Pharma plc (NASDAQ: RPRX). This milestone... more »
-
Bimini Capital Management Announces First Quarter 2024 ResultsVERO BEACH, Fla.--(BUSINESS WIRE)--Bimini Capital Management, Inc. (OTCQB: BMNM), (“Bimini Capital,” “Bimini,” or the “Company”), today announced results of operations for the three-month period en... more »
-
NetApp Hosts Fourth Quarter and Fiscal Year 2024 Financial Results WebcastSAN JOSE, Calif.--(BUSINESS WIRE)--After market close on Thursday, May 30, 2024, NetApp (NASDAQ: NTAP) will announce financial results for the fourth quarter and fiscal year 2024 which ended April ... more »
-
Kopin to Demonstrate Day and Night Readable Warfighter Vision Concepts at SOF WeekWESTBOROUGH, Mass.--(BUSINESS WIRE)--Kopin Corporation (NASDAQ: KOPN) a leading provider of application-specific optical solutions and high-performance micro-displays for defense, enterprise, consu... more »
-
Nerdy to Participate in Needham ConferenceST. LOUIS--(BUSINESS WIRE)--Nerdy Inc. (NYSE: NRDY), a leading platform for delivering live online learning, today announced that management will participate in a fireside chat at the Needham Techn... more »
-
OneSpan Reports First Quarter 2024 Financial ResultsBOSTON--(BUSINESS WIRE)--OneSpan Inc. (NASDAQ: OSPN), the digital agreements security company, today reported financial results for the first quarter ended March 31, 2024. “I am very proud of the O... more »
-
Hologic Announces Financial Results for Second Quarter of Fiscal 2024MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic Announces Financial Results for the Second Quarter of Fiscal 2024 more »
-
Upland Software Reports First Quarter 2024 Financial ResultsAUSTIN, Texas--(BUSINESS WIRE)--Upland Software, Inc. (Nasdaq: UPLD), a leader in cloud-based tools for digital transformation, today announced financial and operating results for the first quarter... more »
-
4M Therapeutics Announces Formation of Clinical Advisory Board with Experts in Neuropsychiatry and NeurodegenerationSKILLMAN, N.J.--(BUSINESS WIRE)--4M Therapeutics Announces Formation of Clinical Advisory Board with Experts in Neuropsychiatry and Neurodegeneration more »
-
Longboard Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate UpdatesLA JOLLA, Calif.--(BUSINESS WIRE)--Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological ... more »